Bill Text: FL S0764 | 2015 | Regular Session | Introduced
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Controlled Substances
Spectrum:
Status: (Failed) 2015-05-01 - Died in Appropriations Subcommittee on Health and Human Services [S0764 Detail]
Download: Florida-2015-S0764-Introduced.html
Bill Title: Controlled Substances
Spectrum:
Status: (Failed) 2015-05-01 - Died in Appropriations Subcommittee on Health and Human Services [S0764 Detail]
Download: Florida-2015-S0764-Introduced.html
Florida Senate - 2015 SB 764
By Senator Evers
2-00616-15 2015764__
1 A bill to be entitled
2 An act relating to controlled substances; amending s.
3 893.03, F.S.; including kratom in a schedule of
4 controlled substances; reenacting ss. 39.01(30)(a) and
5 (g), 316.193(5), 322.2616(2)(c), 327.35(5),
6 440.102(11)(b), 458.3265(1)(e), 459.0137(1)(e),
7 782.04(1)(a) and (4), 787.06(2)(a), 817.563,
8 831.31(1)(a) and (2), 856.015(1)(c), 893.02(4),
9 893.035(2), (7)(a), and (8)(a), 893.0356(2)(a) and
10 (5), 893.05(1), 893.12(2)(b), (c), and (d),
11 893.13(1)(a), (c) through (f), and (h), (2)(a),
12 (4)(b), (5)(b), and (7)(a), 921.0022(3)(b), (c), and
13 (e), F.S., to incorporate the amendment made to s.
14 893.03, F.S., in references thereto; providing an
15 effective date.
16
17 Be It Enacted by the Legislature of the State of Florida:
18
19 Section 1. Paragraph (c) of subsection (1) of section
20 893.03, Florida Statutes, is amended to read:
21 893.03 Standards and schedules.—The substances enumerated
22 in this section are controlled by this chapter. The controlled
23 substances listed or to be listed in Schedules I, II, III, IV,
24 and V are included by whatever official, common, usual,
25 chemical, or trade name designated. The provisions of this
26 section shall not be construed to include within any of the
27 schedules contained in this section any excluded drugs listed
28 within the purview of 21 C.F.R. s. 1308.22, styled “Excluded
29 Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical
30 Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted
31 Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt
32 Anabolic Steroid Products.”
33 (1) SCHEDULE I.—A substance in Schedule I has a high
34 potential for abuse and has no currently accepted medical use in
35 treatment in the United States and in its use under medical
36 supervision does not meet accepted safety standards. The
37 following substances are controlled in Schedule I:
38 (c) Unless specifically excepted or unless listed in
39 another schedule, any material, compound, mixture, or
40 preparation that contains any quantity of the following
41 hallucinogenic substances or that contains any of their salts,
42 isomers, including optical, positional, or geometric isomers,
43 and salts of isomers, if the existence of such salts, isomers,
44 and salts of isomers is possible within the specific chemical
45 designation:
46 1. Alpha-ethyltryptamine.
47 2. 2-Amino-4-methyl-5-phenyl-2-oxazoline (4
48 methylaminorex).
49 3. 2-Amino-5-phenyl-2-oxazoline (Aminorex).
50 4. 4-Bromo-2,5-dimethoxyamphetamine.
51 5. 4-Bromo-2,5-dimethoxyphenethylamine.
52 6. Bufotenine.
53 7. Cannabis.
54 8. Cathinone.
55 9. Diethyltryptamine.
56 10. 2,5-Dimethoxyamphetamine.
57 11. 2,5-Dimethoxy-4-ethylamphetamine (DOET).
58 12. Dimethyltryptamine.
59 13. N-Ethyl-1-phenylcyclohexylamine (PCE) (Ethylamine
60 analog of phencyclidine).
61 14. N-Ethyl-3-piperidyl benzilate.
62 15. N-ethylamphetamine.
63 16. Fenethylline.
64 17. N-Hydroxy-3,4-methylenedioxyamphetamine.
65 18. Ibogaine.
66 19. Lysergic acid diethylamide (LSD).
67 20. Mescaline.
68 21. Methcathinone.
69 22. 5-Methoxy-3,4-methylenedioxyamphetamine.
70 23. 4-methoxyamphetamine.
71 24. 4-methoxymethamphetamine.
72 25. 4-Methyl-2,5-dimethoxyamphetamine.
73 26. 3,4-Methylenedioxy-N-ethylamphetamine.
74 27. 3,4-Methylenedioxyamphetamine.
75 28. N-Methyl-3-piperidyl benzilate.
76 29. N,N-dimethylamphetamine.
77 30. Parahexyl.
78 31. Peyote.
79 32. N-(1-Phenylcyclohexyl)-pyrrolidine (PCPY) (Pyrrolidine
80 analog of phencyclidine).
81 33. Psilocybin.
82 34. Psilocyn.
83 35. Salvia divinorum, except for any drug product approved
84 by the United States Food and Drug Administration which contains
85 Salvia divinorum or its isomers, esters, ethers, salts, and
86 salts of isomers, esters, and ethers, if the existence of such
87 isomers, esters, ethers, and salts is possible within the
88 specific chemical designation.
89 36. Salvinorin A, except for any drug product approved by
90 the United States Food and Drug Administration which contains
91 Salvinorin A or its isomers, esters, ethers, salts, and salts of
92 isomers, esters, and ethers, if the existence of such isomers,
93 esters, ethers, and salts is possible within the specific
94 chemical designation.
95 37. Tetrahydrocannabinols.
96 38. 1-[1-(2-Thienyl)-cyclohexyl]-piperidine (TCP)
97 (Thiophene analog of phencyclidine).
98 39. 3,4,5-Trimethoxyamphetamine.
99 40. 3,4-Methylenedioxymethcathinone.
100 41. 3,4-Methylenedioxypyrovalerone (MDPV).
101 42. Methylmethcathinone.
102 43. Methoxymethcathinone.
103 44. Fluoromethcathinone.
104 45. Methylethcathinone.
105 46. 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2
106 yl)phenol, also known as CP 47,497 and its dimethyloctyl (C8)
107 homologue.
108 47. (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2
109 methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol,
110 also known as HU-210.
111 48. 1-Pentyl-3-(1-naphthoyl)indole, also known as JWH-018.
112 49. 1-Butyl-3-(1-naphthoyl)indole, also known as JWH-073.
113 50. 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl) indole, also
114 known as JWH-200.
115 51. BZP (Benzylpiperazine).
116 52. Fluorophenylpiperazine.
117 53. Methylphenylpiperazine.
118 54. Chlorophenylpiperazine.
119 55. Methoxyphenylpiperazine.
120 56. DBZP (1,4-dibenzylpiperazine).
121 57. TFMPP (3-Trifluoromethylphenylpiperazine).
122 58. MBDB (Methylbenzodioxolylbutanamine).
123 59. 5-Hydroxy-alpha-methyltryptamine.
124 60. 5-Hydroxy-N-methyltryptamine.
125 61. 5-Methoxy-N-methyl-N-isopropyltryptamine.
126 62. 5-Methoxy-alpha-methyltryptamine.
127 63. Methyltryptamine.
128 64. 5-Methoxy-N,N-dimethyltryptamine.
129 65. 5-Methyl-N,N-dimethyltryptamine.
130 66. Tyramine (4-Hydroxyphenethylamine).
131 67. 5-Methoxy-N,N-Diisopropyltryptamine.
132 68. DiPT (N,N-Diisopropyltryptamine).
133 69. DPT (N,N-Dipropyltryptamine).
134 70. 4-Hydroxy-N,N-diisopropyltryptamine.
135 71. N,N-Diallyl-5-Methoxytryptamine.
136 72. DOI (4-Iodo-2,5-dimethoxyamphetamine).
137 73. DOC (4-Chloro-2,5-dimethoxyamphetamine).
138 74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
139 75. 2C-T-4 (2,5-Dimethoxy-4-isopropylthiophenethylamine).
140 76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
141 77. 2C-T (2,5-Dimethoxy-4-methylthiophenethylamine).
142 78. 2C-T-2 (2,5-Dimethoxy-4-ethylthiophenethylamine).
143 79. 2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine).
144 80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
145 81. Butylone (beta-keto-N-methylbenzodioxolylpropylamine).
146 82. Ethcathinone.
147 83. Ethylone (3,4-methylenedioxy-N-ethylcathinone).
148 84. Naphyrone (naphthylpyrovalerone).
149 85. N-N-Dimethyl-3,4-methylenedioxycathinone.
150 86. N-N-Diethyl-3,4-methylenedioxycathinone.
151 87. 3,4-methylenedioxy-propiophenone.
152 88. 2-Bromo-3,4-Methylenedioxypropiophenone.
153 89. 3,4-methylenedioxy-propiophenone-2-oxime.
154 90. N-Acetyl-3,4-methylenedioxycathinone.
155 91. N-Acetyl-N-Methyl-3,4-Methylenedioxycathinone.
156 92. N-Acetyl-N-Ethyl-3,4-Methylenedioxycathinone.
157 93. Bromomethcathinone.
158 94. Buphedrone (alpha-methylamino-butyrophenone).
159 95. Eutylone (beta-Keto-Ethylbenzodioxolylbutanamine).
160 96. Dimethylcathinone.
161 97. Dimethylmethcathinone.
162 98. Pentylone (beta-Keto-Methylbenzodioxolylpentanamine).
163 99. (MDPPP) 3,4-Methylenedioxy-alpha
164 pyrrolidinopropiophenone.
165 100. (MDPBP) 3,4-Methylenedioxy-alpha
166 pyrrolidinobutiophenone.
167 101. Methoxy-alpha-pyrrolidinopropiophenone (MOPPP).
168 102. Methyl-alpha-pyrrolidinohexiophenone (MPHP).
169 103. Benocyclidine (BCP) or
170 benzothiophenylcyclohexylpiperidine (BTCP).
171 104. Fluoromethylaminobutyrophenone (F-MABP).
172 105. Methoxypyrrolidinobutyrophenone (MeO-PBP).
173 106. Ethyl-pyrrolidinobutyrophenone (Et-PBP).
174 107. 3-Methyl-4-Methoxymethcathinone (3-Me-4-MeO-MCAT).
175 108. Methylethylaminobutyrophenone (Me-EABP).
176 109. Methylamino-butyrophenone (MABP).
177 110. Pyrrolidinopropiophenone (PPP).
178 111. Pyrrolidinobutiophenone (PBP).
179 112. Pyrrolidinovalerophenone (PVP).
180 113. Methyl-alpha-pyrrolidinopropiophenone (MPPP).
181 114. JWH-007 (1-pentyl-2-methyl-3-(1-naphthoyl)indole).
182 115. JWH-015 (2-Methyl-1-propyl-1H-indol-3-yl)-1
183 naphthalenylmethanone).
184 116. JWH-019 (Naphthalen-1-yl-(1-hexylindol-3
185 yl)methanone).
186 117. JWH-020 (1-heptyl-3-(1-naphthoyl)indole).
187 118. JWH-072 (Naphthalen-1-yl-(1-propyl-1H-indol-3
188 yl)methanone).
189 119. JWH-081 (4-methoxynaphthalen-1-yl-(1-pentylindol-3
190 yl)methanone).
191 120. JWH-122 (1-pentyl-3-(4-methyl-1-naphthoyl)indole).
192 121. JWH-133 ((6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a
193 tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran)).
194 122. JWH-175 (3-(naphthalen-1-ylmethyl)-1-pentyl-1H
195 indole).
196 123. JWH-201 (1-pentyl-3-(4-methoxyphenylacetyl)indole).
197 124. JWH-203 (2-(2-chlorophenyl)-1-(1-pentylindol-3
198 yl)ethanone).
199 125. JWH-210 (4-ethylnaphthalen-1-yl-(1-pentylindol-3
200 yl)methanone).
201 126. JWH-250 (2-(2-methoxyphenyl)-1-(1-pentylindol-3
202 yl)ethanone).
203 127. JWH-251 (2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3
204 yl)ethanone).
205 128. JWH-302 (1-pentyl-3-(3-methoxyphenylacetyl)indole).
206 129. JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).
207 130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
208 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
209 ol).
210 131. HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan
211 2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]
212 methanol).
213 132. HU-331 (3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-
214 methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene
215 1,4-dione).
216 133. CB-13 (Naphthalen-1-yl-(4-pentyloxynaphthalen-1
217 yl)methanone).
218 134. CB-25 (N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)
219 undecanamide).
220 135. CB-52 (N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)
221 undecanamide).
222 136. CP 55,940 (2-[(1R,2R,5R)-5-hydroxy-2-(3
223 hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol).
224 137. AM-694 (1-[(5-fluoropentyl)-1H-indol-3-yl]-(2
225 iodophenyl)methanone).
226 138. AM-2201 (1-[(5-fluoropentyl)-1H-indol-3-yl]
227 (naphthalen-1-yl)methanone).
228 139. RCS-4 ((4-methoxyphenyl) (1-pentyl-1H-indol-3
229 yl)methanone).
230 140. RCS-8 (1-(1-(2-cyclohexylethyl)-1H-indol-3-yl)-2-(2
231 methoxyphenylethanone).
232 141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4
233 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
234 naphthalenylmethanone).
235 142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4
236 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
237 naphthalenylmethanone).
238 143. Pentedrone (2-(methylamino)-1-phenyl-1-pentanone).
239 144. Fluoroamphetamine.
240 145. Fluoromethamphetamine.
241 146. Methoxetamine.
242 147. Methiopropamine.
243 148. 4-Methylbuphedrone (2-Methylamino-1-(4
244 methylphenyl)butan-1-one).
245 149. APB ((2-aminopropyl)benzofuran).
246 150. APDB ((2-aminopropyl)-2,3-dihydrobenzofuran).
247 151. UR-144 ((1-pentyl-1H-indol-3-yl)(2,2,3,3
248 tetramethylcyclopropyl)methanone).
249 152. XLR11 ((1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3
250 tetramethylcyclopropyl)methanone).
251 153. (1-(5-chloropentyl)-1H-indol-3-yl)(2,2,3,3
252 tetramethylcyclopropyl)methanone.
253 154. AKB48 (1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H
254 indazole-3-carboxamide).
255 155. AM-2233((2-iodophenyl)[1-[(1-methyl-2
256 piperidinyl)methyl]-1H-indol-3-yl]-methanone).
257 156. STS-135 (1-(5-fluoropentyl)-N-tricyclo[3.3.1.13,7]dec
258 1-yl-1H-indole-3-carboxamide).
259 157. URB-597 ((3’-(aminocarbonyl)[1,1’-biphenyl]-3-yl)
260 cyclohexylcarbamate).
261 158. URB-602 ([1,1’-biphenyl]-3-yl-carbamic acid,
262 cyclohexyl ester).
263 159. URB-754 (6-methyl-2-[(4-methylphenyl)amino]-1
264 benzoxazin-4-one).
265 160. 2C-D (2-(2,5-Dimethoxy-4-methylphenyl)ethanamine).
266 161. 2C-H (2-(2,5-Dimethoxyphenyl)ethanamine).
267 162. 2C-N (2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine).
268 163. 2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine).
269 164. 25I-NBOMe (4-iodo-2,5-dimethoxy-N-[(2
270 methoxyphenyl)methyl]-benzeneethanamine).
271 165. 3,4-Methylenedioxymethamphetamine (MDMA).
272 166. PB-22 (1-pentyl-8-quinolinyl ester-1H-indole-3
273 carboxylic acid).
274 167. 5-Fluoro PB-22 (8-quinolinyl ester-1-(5-fluoropentyl)
275 1H-indole-3-carboxylic acid).
276 168. BB-22 (1-(cyclohexylmethyl)-8-quinolinyl ester-1H
277 indole-3-carboxylic acid).
278 169. 5-Fluoro AKB48 (N-((3s,5s,7s)-adamantan-1-yl)-1-(5
279 fluoropentyl)-1H-indazole-3-carboxamide).
280 170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
281 pentyl-1H-indazole-3-carboxamide).
282 171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
283 (4-fluorobenzyl)-1H-indazole-3-carboxamide).
284 172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
285 1-pentyl-1H-indazole-3-carboxamide).
286 173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
287 yl)-1-(fluoropentyl)-1H-indole-3-carboxamide).
288 174. 25B-NBOMe (4-bromo-2,5-dimethoxy-N-[(2
289 methoxyphenyl)methyl]-benzeneethanamine).
290 175. 2C-C-NBOMe (4-chloro-2,5-dimethoxy-N-[(2
291 methoxyphenyl)methyl]-benzeneethanamine).
292 176. Kratom (Mitragyna speciosa).
293 Section 2. Paragraphs (a) and (g) of subsection (30) of s.
294 39.01, subsection (5) of s. 316.193, paragraph (c) of subsection
295 (2) of s. 322.2616, subsection (5) of s. 327.35, paragraph (b)
296 of subsection (11) of s. 440.102, paragraph (e) of subsection
297 (1) of s. 458.3265, paragraph (e) of subsection (1) of s.
298 459.0137, paragraph (a) of subsection (1) and subsection (4) of
299 s. 782.04, paragraph (a) of subsection (2) of s. 787.06, s.
300 817.563, paragraph (a) of subsection (1) and subsection (2) of
301 s. 831.31, paragraph (c) of subsection (1) of s. 856.015,
302 subsection (4) of s. 893.02, subsection (2), paragraph (a) of
303 subsection (7), and paragraph (a) of subsection (8) of s.
304 893.035, paragraph (a) of subsection (2) and subsection (5) of
305 s. 893.0356, subsection (1) of s. 893.05, paragraphs (b), (c),
306 and (d) of subsection (2) of s. 893.12, paragraphs (a), (c)
307 through (f), and (h) of subsection (1), paragraph (a) of
308 subsection (2), paragraph (b) of subsection (4), paragraph (b)
309 of subsection (5), and paragraph (a) of subsection (7) of s.
310 893.13, and paragraphs (b), (c), and (e) of subsection (3) of s.
311 921.0022, Florida Statutes, are reenacted for the purpose of
312 incorporating the amendment made by this act to s. 893.03,
313 Florida Statutes, in references thereto.
314 Section 3. This act shall take effect October 1, 2015.
